ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$233.74

Market cap

$36.72B

P/E Ratio

50.92

Dividend/share

N/A

EPS

$4.59

Enterprise value

$37.91B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
The equity has soared by 121% YoY
The company's gross profit rose by 36% YoY
ILMN's net income is up by 11% year-on-year but it is down by 8% since the previous quarter
Illumina's debt has decreased by 10% YoY but it has increased by 3% QoQ
The quick ratio has plunged by 67% YoY and by 25% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com
Peers: PKI PACB A TMO

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
157.1M
Market cap
$36.72B
Enterprise value
$37.91B
Valuations
Price to earnings (P/E)
50.92
Price to book (P/B)
3.37
Price to sales (P/S)
7.88
EV/EBIT
42.03
EV/EBITDA
31.7
EV/Sales
8.14
Earnings
Revenue
$4.66B
EBIT
$902M
EBITDA
$1.2B
Free cash flow
$208M
Per share
EPS
$4.59
Free cash flow per share
$1.32
Book value per share
$69.39
Revenue per share
$29.66
TBVPS
$31.54
Balance sheet
Total assets
$15.27B
Total liabilities
$4.38B
Debt
$2.54B
Equity
$10.9B
Working capital
$1.27B
Liquidity
Debt to equity
0.23
Current ratio
1.85
Quick ratio
1.36
Net debt/EBITDA
1
Margins
EBITDA margin
25.7%
Gross margin
68.8%
Net margin
15%
Operating margin
-2.9%
Efficiency
Return on assets
5.2%
Return on equity
7.5%
Return on invested capital
18.4%
Return on capital employed
6.5%
Return on sales
19.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
0.08%
1 week
5.92%
1 month
-30.54%
1 year
-38.66%
YTD
-38.56%
QTD
-33.1%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.66B
Gross profit
$3.2B
Operating income
-$133M
Net income
$700M
Gross margin
68.8%
Net margin
15%
The operating income has plunged by 123% YoY and by 8% from the previous quarter
Illumina's operating margin has plunged by 117% YoY and by 7% from the previous quarter
The company's gross profit rose by 36% YoY
Illumina's revenue has increased by 34% YoY and by 2.9% QoQ

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
50.92
P/B
3.37
P/S
7.88
EV/EBIT
42.03
EV/EBITDA
31.7
EV/Sales
8.14
The stock's price to earnings (P/E) is 34% less than its last 4 quarters average of 77.2 and 18% less than its 5-year quarterly average of 62.3
Illumina's EPS has decreased by 9% QoQ but it has increased by 6% YoY
The equity has soared by 121% YoY
The price to book (P/B) is 68% lower than the 5-year quarterly average of 10.4 and 54% lower than the last 4 quarters average of 7.4
ILMN's P/S is 44% below its last 4 quarters average of 14.1 and 42% below its 5-year quarterly average of 13.7
Illumina's revenue has increased by 34% YoY and by 2.9% QoQ

Efficiency

How efficient is Illumina business performance
The ROE has contracted by 44% YoY and by 23% from the previous quarter
The company's return on assets fell by 36% YoY and by 19% QoQ
Illumina's return on sales has decreased by 26% YoY and by 7% QoQ
ILMN's return on invested capital is up by 5% year-on-year but it is down by 3.7% since the previous quarter

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets has soared by 74% YoY
The quick ratio has plunged by 67% YoY and by 25% from the previous quarter
Illumina's debt is 77% lower than its equity
The equity has soared by 121% YoY
The debt to equity has dropped by 60% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.